Product image of Infanrix Tetra (Poliovirus (Inactivated) Type 3 (Saukett Strain), Pertussis Filamentous Haemagglutinin Adsorbed On A) supplied by GNH India

Infanrix Tetra

Active Ingredient:
Poliovirus (Inactivated) Type 3 (Saukett Strain), Pertussis Filamentous Haemagglutinin Adsorbed On A
Origin:
EU

Infanrix Tetra (Poliovirus (Inactivated) Type 3 (Saukett Strain), Pertussis Filamentous Haemagglutinin Adsorbed On A)

Poliovirus (Inactivated) Type 3 (Saukett Strain), Pertussis Filamentous Haemagglutinin, the active ingredient in Infanrix Tetra, is a vaccine presented as a vaccine formulation for intramuscular use. It prevents poliomyelitis type 3 and pertussis in infants and children.

GNH India supplies Infanrix Tetra as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Glaxosmithkline Single Member A.E.B.E.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Infanrix Tetra is a combination vaccine that targets viral and bacterial agents responsible for serious childhood diseases.

  • Poliomyelitis (type 3): provides active immunity against poliovirus type 3, reducing the risk of paralytic disease.
  • Pertussis (whooping cough): induces protective antibodies against pertussis filamentous haemagglutinin, helping prevent infection.
  • Routine childhood immunisation: administered as part of the standard paediatric schedule to protect against polio and pertussis.

How It Works

  • The inactivated poliovirus type 3 antigen stimulates the host's B‑cell response to produce neutralising antibodies against poliovirus, while the pertussis filamentous haemagglutinin component elicits a Th2‑biased immune response that generates antibodies targeting the pertussis bacterium. Together, these antigens activate adaptive immunity, establishing long‑lasting protection without causing disease.

Side Effects

Common Side Effects

  • Injection site pain: mild to moderate discomfort at the injection site.
  • Redness or swelling: localized erythema or edema.
  • Fever: low‑grade temperature rise within 24‑48 hours.
  • Irritability: increased fussiness in infants.
  • Loss of appetite: temporary reduction in feeding.
  • Headache: mild headache reported in some recipients.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate medical attention.
  • Seizures: rare febrile convulsions following vaccination.
  • Encephalopathy: extremely rare inflammation of the brain.
  • Guillain‑Barré syndrome: very rare autoimmune neuropathy.
  • Severe allergic reaction: including angioedema or bronchospasm.

Precautions & Warnings

Infanrix Tetra should be administered only after careful assessment of the individual's health status.

  • Screen for severe allergic reactions: avoid if known hypersensitivity to any vaccine component.
  • Delay vaccination if moderate or severe acute illness is present: postpone until recovery.
  • Consult healthcare provider for immunocompromised patients: immune response may be diminished.
  • Observe child for 15 minutes after injection: monitor for immediate hypersensitivity.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Vaccines can interact with other agents that affect the immune system.

Major Interactions (Avoid)

  • Live viral vaccines: simultaneous administration may reduce immune response to one or both vaccines.
  • Immunoglobulins or blood products: can neutralise vaccine antigens and diminish efficacy.

Moderate Interactions (Monitor Closely)

  • Antipyretics (e.g., acetaminophen): may reduce fever but generally do not affect immunogenicity.
  • Concurrent inactivated vaccines: generally safe but monitor for increased reactogenicity.
  • Immunosuppressive therapy: may lower antibody production, requiring serologic follow‑up.

Frequently Asked Questions

Infanrix Tetra is a combination vaccine indicated for the prevention of poliomyelitis caused by poliovirus type 3 and for protection against pertussis (whooping cough) in infants and young children as part of routine immunisation programmes.

The inactivated poliovirus type 3 antigen triggers the body to produce neutralising antibodies that block viral replication, while the pertussis filamentous haemagglutinin component stimulates an antibody response against the pertussis bacterium, together establishing active immunity without causing disease.

The dose and schedule are determined by the prescribing healthcare professional based on national immunisation guidelines. Infanrix Tetra is administered by a single‑dose intramuscular injection according to the recommended pediatric timetable.

Safety data for use during pregnancy are limited, and the vaccine is generally not recommended for pregnant women unless the benefit outweighs potential risk. Breastfeeding is not a contraindication, but mothers should discuss any concerns with their healthcare provider.

To place an order, submit an enquiry on the Infanrix Tetra product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.

Infanrix Tetra focuses on poliovirus type 3 and pertussis antigens, whereas other combination vaccines (e.g., DTPa‑IPV) may include additional diphtheria, tetanus or broader polio serotypes. Choice depends on national schedules, antigen coverage, and regulatory approvals.

Infanrix Tetra must be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. The vaccine should be kept in its original packaging until use to maintain potency.

The vaccine is administered as a single intramuscular injection, typically into the anterolateral thigh of infants or the deltoid muscle of older children. Proper aseptic technique and post‑vaccination observation are recommended.

Serious adverse events, although rare, include anaphylaxis, seizures (febrile convulsions), encephalopathy, and Guillain‑Barré syndrome. Immediate medical attention is required if signs of a severe allergic reaction or neurological symptoms develop after vaccination.

Infanrix Tetra is contraindicated in individuals with a known severe allergy to any vaccine component or who have experienced encephalopathy following a previous pertussis‑containing vaccine. It should also be deferred in persons with moderate or severe acute illness until recovery.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Poliovirus (Inactivated) Type 3 (Saukett Strain), Pertussis Filamentous Haemagglutinin Adsorbed On A

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT